# Safety and Efficacy Study of MGuard Stent After a Heart Attack

Study · id `cardio:ct-nct01368471` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT01368471](<https://clinicaltrials.gov/study/NCT01368471>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT01368471

Browse, organ or system: Heart  
Browse, condition area: Coronary and vascular disease; Acute care and long-term living  

## In plain language

A phase 4 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 433 participants.

## Technical summary

Registry record NCT01368471. Randomized; single masking; primary purpose treatment. Start 2011-06 (registry gives no type); primary completion 2012-06 (actual). Results not posted.

## Key facts

- Design: Interventional study; randomized; single masking; primary purpose treatment
- Phase: Phase 4
- Enrolled: 433 participants (enrolled count; ClinicalTrials.gov record NCT01368471, source copy `cardio:ctgov-nct01368471-2013-05-29`, retrieved 2026-10-26)
- Start date: 2011-06 (registry gives no type) (ClinicalTrials.gov record NCT01368471, source copy `cardio:ctgov-nct01368471-2013-05-29`, retrieved 2026-10-26)
- Primary completion: 2012-06 (actual) (ClinicalTrials.gov record NCT01368471, source copy `cardio:ctgov-nct01368471-2013-05-29`, retrieved 2026-10-26)
- Completion: 2012-06 (actual) (ClinicalTrials.gov record NCT01368471, source copy `cardio:ctgov-nct01368471-2013-05-29`, retrieved 2026-10-26)
- Countries: Poland; South Africa (ClinicalTrials.gov record NCT01368471, source copy `cardio:ctgov-nct01368471-2013-05-29`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "COMPLETED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct01368471-2013-05-29`, retrieved 2026-10-26)

## The registry's words

- Brief title: Safety and Efficacy Study of MGuard Stent After a Heart Attack
- Acronym: MASTER
- Condition: Myocardial Infarction
- Intervention (Device): MGuard
- Intervention (Device): Control BMS or DES
- Lead sponsor: InspireMD
- Lead sponsor class: INDUSTRY

## Connected pages

- Registry condition terms include this condition: Heart attack (myocardial infarction) (`cardio:myocardial-infarction`)
- Registry condition terms include this condition: ST-elevation heart attack (STEMI) (`cardio:stemi`)
- Registry lists this organization as the lead sponsor: InspireMD (`cardio:org-inspiremd`)

### Other papers using this trial's data

- Registry lists this paper as a derived reference; the paper's PubMed record names this trial's registry number and no other, PubMed types it as a trial report dated on or after the primary completion, neither its types nor its title mark it as a protocol, a design, an observational study or work outside the trial's own data, and PubMed shows no retraction or expression of concern: Prospective, Randomized, Multicenter Evaluation of a Polyethylene Terephthalate Micronet Mesh-Covered Stent (MGuard) in ST-Segment Elevation Myocardial Infarction: The MASTER Trial (`cardio:pubmed-23103033`)
- Registry lists this paper as a derived reference; the paper's PubMed record names this trial's registry number and no other, PubMed types it as a trial report dated on or after the primary completion, neither its types nor its title mark it as a protocol, a design, an observational study or work outside the trial's own data, and PubMed shows no retraction or expression of concern: Efficacy of an Embolic Protection Stent as a Function of Delay to Reperfusion in ST-Segment Elevation Myocardial Infarction (from the MASTER Trial) (`cardio:pubmed-25277335`)
- Registry lists this paper as a derived reference; the paper's PubMed record names this trial's registry number and no other, PubMed types it as a trial report dated on or after the primary completion, neither its types nor its title mark it as a protocol, a design, an observational study or work outside the trial's own data, and PubMed shows no retraction or expression of concern: Mesh-covered embolic protection stent implantation in ST-segment-elevation myocardial infarction: final 1-year clinical and angiographic results from the MGUARD for acute ST elevation reperfusion trial (`cardio:pubmed-25603802`)

Courtesy of the U.S. National Library of Medicine.

## Provenance

Content hash: 4c8d3ce620acd334e8f2f7e66ada36ca380a1e6c1f65c8d45352a222124cfd50
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
